文献速递心律失常

血浆癌抗原125水平作为绝经后女性新发房颤的生物标志物

Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
PubMed 文献 · Heart · 2017-03-11

研究纳入746名绝经后女性,在2005至2015年十年观察期内31人(4.2%)发生房颤;发生房颤者CA-125和hs-CRP水平显著高于未发生者,Cox回归显示年龄(HR 1.3)和CA-125(HR 1.29)是新发房颤的独立预测因子。

要点

  • 绝经后健康女性中,新发房颤者CA-125水平显著高于未发生者。
  • 年龄(HR 1.3)与血浆CA-125(HR 1.29)是新发房颤的独立预测因子。
  • 高CA-125水平可能与健康绝经后女性新发房颤相关。

核心结论

  • 高CA-125水平可能与健康绝经后女性新发房颤相关。

研究设计与样本

  • 2005至2015年间在本院进行年度健康体检的2086名女性中,1012名为绝经后女性,排除收缩功能障碍、慢性炎症性疾病、慢性阻塞性肺疾病、房颤史或肿瘤性疾病史者后,共746名绝经后女性接受包括脑钠肽、高敏C反应蛋白和CA-125在内的全面体检。

主要发现

  • 十年观察期内31名参与者(4.2%)记录到房颤。
  • 发生房颤者平均年龄75±6岁,高于未发生者的68±8岁。
  • 发生房颤者CA-125为11.4±6.3 U/mL,高于未发生者的7.7±3.2 U/mL(p<0.01)。
  • 发生房颤者hs-CRP为0.10±0.11 mg/dL,高于未发生者的0.07±0.08 mg/dL(p<0.05)。
  • Cox回归分析显示年龄(HR 1.3;95% CI 1.08至1.57;p<0.01)和血浆CA-125水平(HR 1.29;95% CI 1.10至1.51;p=0.02)是新发房颤的独立预测因子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Plasma cancer antigen (CA)-125 is a tumour marker recently shown to be associated with systolic heart failure and new-onset atrial fibrillation (AF) after myocardial infarction. However, no reports have described the relationship between CA-125 and new-onset AF in healthy postmenopausal women. The aim of the present study was to evaluate the relationship between CA-125 and new-onset AF in postmenopausal women. METHODS: Between 2005 and 2015, 2086 women, including 1012 postmenopausal women, visited our hospital for annual health check-ups. We excluded patients with systolic dysfunction, chronic inflammatory disease, chronic obstructive pulmonary disease, histories of AF or neoplastic diseases. A total of 746 postmenopausal women underwent thorough physical examinations, including those for biomarkers such as brain natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP) and CA-125. RESULTS: During the 10-year observation period, AF was documented in 31 participants (4.2%). The mean age of participants developing AF (75±6 years) was higher than that of those without AF (68±8 years). Participants developing AF showed significantly higher CA-125 (11.4±6.3 U/mL) and hs-CRP (0.10±0.11 mg/dL) levels than did those without AF (7.7±3.2 U/mL, p<0.01; 0.07±0.08 mg/dL, p<0.05). Cox regression analyses revealed ageing (HR 1.3; 95% CI 1.08 to 1.57; p<0.01) and plasma CA-125 levels (HR 1.29; 95% CI 1.10 to 1.51; p=0.02) as independent predictors of AF. CONCLUSIONS: High CA-125 levels might be associated with new-onset AF in healthy postmenopausal women.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Sekiguchi H, Shimamoto K, Takano M, et al. Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women. Heart. 2017. PMID: 28285269. doi:10.1136/heartjnl-2016-310272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。